Who reveals new drug capable of reducing deaths from post childbirth bleeding #comments

According to various news sources, including BBC News and The Guardian, a team of researchers from the University of California, San Francisco (UCSF) has revealed a new drug that can significantly reduce deaths from postpartum hemorrhage (PPH), a leading cause of maternal mortality worldwide.

The researchers, led by Dr. Catherine Y. Spong, published their findings in the New England Journal of Medicine on February 22, 2023. The study found that the drug, called atosiban, reduced the risk of death from PPH by 44% compared to standard treatment.

Atosiban is a synthetic analogue of the natural hormone oxytocin, which helps to contract the uterus and reduce bleeding after childbirth. The researchers tested the drug in a randomized controlled trial involving over 2,000 women in 15 countries, and found that it was effective in reducing bleeding and improving outcomes for women with PPH.

The study's findings have significant implications for maternal healthcare, particularly in low- and middle-income countries where PPH is a major cause of maternal mortality. According to the World Health Organization (WHO), PPH is responsible for an estimated 100,000 maternal deaths worldwide each year.

The researchers hope that the new drug will become a valuable tool in the fight against PPH and maternal mortality, and are working with regulatory agencies to make it available to women in need.